Actelion To Pay $360M To Settle Federal Drug Co-Pay Kickback Allegations
BOSTON — Actelion Pharmaceuticals US Inc. has agreed to pay $360 million plus interest to resolve federal allegations that it paid kickbacks through a charitable foundation to illegally pay drug co-pays...To view the full article, register now.
Already a subscriber? Click here to view full article